Literature DB >> 10658377

Clinical role of blood heparin level monitoring during open heart surgery.

T Ohata1, Y Sawa, S Ohtake, M Nishimura, C J Chan, K Suzuki, H Matsuda.   

Abstract

Protamine has been used for neutralizing heparin and its dosage is decided by the initial fixed dose of heparin. Adequate protamine neutralization is very important to reduce complications. To attenuate excess reactions, in particular, whole blood heparin concentration during and after cardiopulmonary bypass was measured using Hepcon, and the efficacy of optimal protamine dose in open heart surgery was evaluated. Twenty patients were randomly divided into two comparable groups, P and C. In the C group, heparin was neutralized with an initial fixed dose of protamine, 1.67 mg protamine per milligram total heparin (n = 8). In the P group, protamine dose was determined for residual heparin concentration (n = 12). In the P group, blood heparin concentrations at 60 minutes after the establishment of cardiopulmonary bypass, just after cardiopulmonary bypass and first protamine administration were 2.35 +/- 0.14, 2.31 +/- 0.17 and 0.13 +/- 0.08 U/ml, respectively. Concentrations reached zero with the second protamine administration. The requirement of transfusion (659 +/- 224 vs. 1559 +/- 323 ml, p = 0.0314), pulmonary vascular resistance index just after the protamine administration (190 +/- 22 vs. 286 +/- 18 dyne.s.cm-5.m2, p = 0.0137) and the IL-8 levels (just after protamine: 26.9 +/- 5.1 vs. 43.5 +/- 5.9 pg/ml, p = 0.0499, 12 hours after cardiopulmonary bypass: 37.1 +/- 12.1 vs. 86.8 +/- 20.0, p = 0.0435) in the P group were significantly lower than those in the C group. These data suggested that heparin level monitoring in whole blood may be useful to determine the optimal dose of protamine resulting in the decrease of a requirement of blood components in open heart surgery and attenuating in transient pulmonary hypertension and excess protamine-induced inflammatory reactions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10658377     DOI: 10.1007/bf03218071

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN: 1344-4964


  17 in total

1.  Coagulation defects in neonates during cardiopulmonary bypass.

Authors:  F H Kern; N J Morana; J J Sears; P R Hickey
Journal:  Ann Thorac Surg       Date:  1992-09       Impact factor: 4.330

2.  Protamine-induced hypotension in heart operations: application of the concept of ventricular-arterial coupling.

Authors:  M Oe; T Asou; S Morita; H Yasui; K Tokunaga
Journal:  J Thorac Cardiovasc Surg       Date:  1996-08       Impact factor: 5.209

3.  Whole blood heparin concentration measurements by automated protamine titration agree with plasma anti-Xa measurements.

Authors:  G J Despotis; J H Joist; L T Goodnough; S A Santoro; E Spitznagel
Journal:  J Thorac Cardiovasc Surg       Date:  1997-03       Impact factor: 5.209

Review 4.  Organ dysfunction after cardiopulmonary bypass. A systemic inflammatory reaction initiated by the extracorporeal circuit.

Authors:  S Westaby
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

5.  Effects of protamine administration after cardiopulmonary bypass on complement, blood elements, and the hemodynamic state.

Authors:  J K Kirklin; D E Chenoweth; D C Naftel; E H Blackstone; J W Kirklin; D D Bitran; J G Curd; J G Reves; P N Samuelson
Journal:  Ann Thorac Surg       Date:  1986-02       Impact factor: 4.330

6.  Effect of cardiopulmonary bypass under tepid temperature on inflammatory reactions.

Authors:  T Ohata; Y Sawa; K Kadoba; T Masai; H Ichikawa; H Matsuda
Journal:  Ann Thorac Surg       Date:  1997-07       Impact factor: 4.330

7.  Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung.

Authors:  S L Kunkel; T Standiford; K Kasahara; R M Strieter
Journal:  Exp Lung Res       Date:  1991 Jan-Feb       Impact factor: 2.459

8.  The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.

Authors:  G J Despotis; J H Joist; C W Hogue; A Alsoufiev; K Kater; L T Goodnough; S A Santoro; E Spitznagel; M Rosenblum; D G Lappas
Journal:  J Thorac Cardiovasc Surg       Date:  1995-07       Impact factor: 5.209

9.  Platelet aggregation following heparin and protamine administration.

Authors:  N Ellison; L H Edmunds; R W Colman
Journal:  Anesthesiology       Date:  1978-01       Impact factor: 7.892

10.  Complement and neutrophil activation during cardiopulmonary bypass: a study in the complement-deficient dog.

Authors:  A M Gillinov; J M Redmond; J A Winkelstein; K J Zehr; A Herskowitz; W A Baumgartner; D E Cameron
Journal:  Ann Thorac Surg       Date:  1994-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.